The Column Group, LLC
- Investor (buy-side or sell-side research)
- Biotech or pharma, therapeutic R&D
Seeking to in-license and spin-out single-asset NewCos, or invest in seed or pre-seed stage asset-centric companies. Our focus is on small molecule, antibody, and siRNA modalities.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}